Related Experiment Videos
Hormone replacement therapy and biological aggressiveness of breast cancer
Lancet (London, England)
|December 24, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Assessment of PARP protein expression in epithelial ovarian cancer by ELISA pharmacodynamic assay and immunohistochemistry.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2016
Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies.
Clinical oncology (Royal College of Radiologists (Great Britain))·2015
Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Understanding peripheral arterial disease in the current era.
Lancet (London, England)·2026
Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead.
Lancet (London, England)·2026